ALXN Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q1 2020 Earnings Call Transcript 6 years ago Alexion Pharmaceuticals Inc (ALXN) Q1 2020 earnings call dated May. 06, 2020 Corporate Participants: Chris Stevo — Head of Investor Relations Ludwig… Alexion Pharmaceuticals (ALXN) Q1 profit drops 5% but beats estimates 6 years ago Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported its financial results for the quarter ended March 31, 2020, on Wednesday before the… Alexion (ALXN) to acquire Portola (PTLA) for $1.44 billion 6 years ago Alexion Pharmaceuticals (NASDAQ: ALXN) announced today that it will be acquiring commercial-stage biopharmaceutical company Portola Pharmaceuticals (NASDAQ: PTLA) for an… Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q4 2019 Earnings Call Transcript 6 years ago Alexion Pharmaceuticals Inc (NASDAQ: ALXN) Q4 2019 Earnings Conference Call January 30, 2020 Corporate Participants: Morgan Sanford — Director of Investor Relations Ludwig… Alexion Pharmaceuticals, Inc. (ALXN): Earnings Snapshot 6 years ago — Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported earnings of $2.71 per share in the fourth-quarter 2019, vs. $2.60 per share… Alexion Pharmaceuticals, (ALXN): Q3 2019 Earnings Snapshot 6 years ago Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported third-quarter 2019 earnings of $2.79 per share, vs. $2.47 per share expected. Revenues grew…